Boo Pharmaceuticals-B (02142.HK) issued 4.875 million share purchase rights.

China Securities Journal APP News, Haobao Pharmaceutical Group-B (02142.HK) announced that on April 29, 2025, in accordance with the share purchase plan adopted by the company's shareholders on November 23, 2020, the company granted 4.875 million share options to eligible participants, but the options will only become effective after being accepted by the grantee.